Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 7, 2009
Boston Scientific Corporation is scheduled to participate in the upcoming JP Morgan Health Care Conference in San Francisco. Jim Tobin, Chief...
-
Jan 6, 2009
Acquisition demonstrates Company's commitment to innovation in drug-eluting stent technology NATICK, Mass., Jan. 6 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced that it...
-
Dec 18, 2008
Boston Scientific Corporation today announced enrollment of the first patient...
-
Dec 15, 2008First low-profile, pre-mounted stent approved specifically for use in renal arteries
Boston Scientific Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved the Express® SD Renal Monorail®...
-
Nov 24, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray Health Care Conference, which is being held December 2 -...
-
Nov 10, 2008New design provides more options for treating patients with complex lesions
Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval from the U.S. Food and Drug Administration to market its...
-
Oct 29, 2008
Boston Scientific Corporation (NYSE: BSX) today welcomed passage of legislation to help active members of the U.S. armed forces and service...
-
Oct 27, 2008Confirms clinical value and cost-effectiveness of spinal cord stimulation
Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by the U.K.'s National Institute for Health and Clinical Excellence (NICE)...
-
Oct 23, 2008Leading carotid stent in Europe and other international markets now available in the United States
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved its Carotid WALLSTENT®...
-
Oct 21, 2008
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the third quarter ended September 30, 2008, as well as guidance for...